Column Capital Advisors’s LeonaBio Inc LONA Stock Holding History

Column Capital Advisors’s Portfolio LONA Stock Details LONA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-40	Closed	-$1K	–	840
2022 Q3	$1K	Buy	+40	New	+$1.38K	﹤0.01%	665

Other funds holding LONA

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PFO

Pathstone Family Office Englewood, New Jersey $13.1B AUM 20.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

Bristlecone Advisors Bellevue, Washington $1.2B AUM 19.79% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Column Capital Advisors's LONA Position: Q4 2022 in Review

Column Capital Advisors sold out of LeonaBio Inc (LONA) in Q4 2022, closing a stake of 40 shares — an estimated $1K sold.

Column Capital Advisors first reported a position in LONA in Q3 2022 and held it in 1 quarter. The position peaked at $1K in Q3 2022. 92 funds tracked by Wall St. Rank hold LONA as of Q4 2022.

Column Capital Advisors reported no remaining LeonaBio Inc position as of Q4 2022 after selling out during the quarter.
Column Capital Advisors sold 40 LeonaBio Inc shares in Q4 2022, an estimated $1K.
Column Capital Advisors first reported a position in LeonaBio Inc in Q3 2022 and held it in 1 quarter.
Column Capital Advisors's LeonaBio Inc position peaked at $1K in Q3 2022.
92 funds tracked by Wall St. Rank held LeonaBio Inc as of Q4 2022.

Based on Column Capital Advisors's 13F filing for Q4 2022, filed 6 Feb 2023.